|Event:||31st Annual J.P. Morgan Healthcare Conference, San Francisco|
|Date:||Monday, January 7, 2013|
|Time:||8:30 a.m. PST|
One of these biopharma executives, or the grouped nominees, will win the Swanson Trophy, named in honor of Robert Swanson, Genentech's founding CEO. Here are the best biopharma CEOs.
Analysts are concerned about Valeant Pharmaceuticals but that can only help Action Alerts PLUS holding Allergan, Cramer says.
With Pfizer's need for tax savings and pipeline products, an offer is expected to hand Allergan shareholders a 30% premium.
Drugmaker Allergan withholds guidance for future quarters, following its announcement last week that it's selling its generic drug business to Teva Pharmaceuticals.